Equillium (EQ) Capital Expenditures (2018 - 2026)
Equillium's (EQ) quarterly Capital Expenditures came in at $3000.0 in Q1 2026, down 25.0% year-on-year from $4000.0 in Q1 2025, and down 93.18% on a QoQ basis from $44000.0 in Q4 2025.
Equillium (EQ) Capital Expenditures (2018 - 2026) Analysis & Trends
Equillium (EQ) has 9 years of Capital Expenditures data on file, last reported at $3000.0 in Q1 2026.
- On a quarterly basis, Capital Expenditures fell 25.0% year-over-year to $3000.0 in Q1 2026; TTM through Mar 2026 was $47000.0, a 32.86% decrease from a year earlier, with the FY2025 full-year figure at $48000.0, down 43.53% from the prior year.
- Capital Expenditures for Q1 2026 stood at $3000.0, down from $44000.0 in the prior quarter.
- Over the last five years, Capital Expenditures for EQ reached as high as $276000.0 in Q4 2022 and fell as low as -$274000.0 in Q3 2022.
- Historically, Capital Expenditures has averaged $40909.1 across 5 years, with a median of $35000.0 in 2023.
- Across the five-year window, Capital Expenditures sank 956.25% in 2022 and jumped 1000.0% in 2025, its largest moves.
- Year by year, Capital Expenditures stood at $276000.0 in 2022, then sank by 87.32% to $35000.0 in 2023, then plunged by 88.57% to $4000.0 in 2024, then soared by 1000.0% to $44000.0 in 2025, then sank by 93.18% to $3000.0 in 2026.
- Per Business Quant data, the three most recent Capital Expenditures figures were $3000.0 in Q1 2026, $44000.0 in Q4 2025, and $4000.0 in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capital Expenditures (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | -8,939.03 |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 43.25 Mn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 133.40 Mn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 230.60 Mn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | - |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | 786,000.00 |
| 10 | Equillium | 242.14 Mn | 242.14 Mn | - | 3,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 3,000.00 |
| Mar 31, 2026 | 3,000.00 |
| Dec 31, 2025 | 44,000.00 |
| Dec 31, 2025 | 44,000.00 |
| Mar 31, 2025 | 4,000.00 |
| Mar 31, 2025 | 4,000.00 |
| Dec 31, 2024 | 4,000.00 |
| Dec 31, 2024 | 4,000.00 |
| Jun 30, 2024 | 62,000.00 |
| Jun 30, 2024 | 62,000.00 |
| Mar 31, 2024 | 19,000.00 |
| Mar 31, 2024 | 19,000.00 |
| Dec 31, 2023 | 35,000.00 |
| Dec 31, 2023 | 35,000.00 |
| Dec 31, 2022 | 276,000.00 |
| Dec 31, 2022 | 276,000.00 |
| Sep 30, 2022 | -274,000.00 |
| Sep 30, 2022 | -274,000.00 |
| Jun 30, 2022 | 241,000.00 |
| Jun 30, 2022 | 241,000.00 |